Skip to main content

Advertisement

Log in

Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation

  • Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

The French Pediatric Infectious Diseases Group set up an active surveillance network to analyze the clinical and biological features of pneumococcal meningitis and the impact of the seven-valent pneumococcal conjugate vaccine (PCV7). From 2001 to 2005, 234 pediatric wards working with 166 microbiology laboratories enrolled all children with pneumococcal meningitis. Risk factors, signs and symptoms, vaccination status, cerebrospinal fluid analysis, treatments and case fatality rates were recorded. One hundred and sixty-nine centers (169/234) reported 616 cases, median age was 0.9 years and 67.2% of children were ≤2 years old. Underlying conditions were present in 13.1% of cases. The proportion of penicillin non-susceptible strains was 48.7%. Vancomycin plus a third-generation cephalosporin was prescribed in 92.7% of cases, and steroids were given before antibiotic treatment in 16.5% of cases. The case fatality rate was 10.8% overall and was not related to age, antibiotic susceptibility or steroid use. In children 2 to 24 months old compared to the prevaccinal period (2001–2002) a decrease of 28.4% of the number of cases was observed in 2005 (P < 0.05). Among children 2 to 24 months old, the proportion of serotypes covered by the PCV7 fell from 39/57 (68.4%) in 2001–2002 to 19/45 (42.2%) in 2005, while the proportion of non-vaccine serotypes and related serotypes increased respectively from 9/57 (15.8%) and 9/57 (15.8%) in 2001–2002 to 14/45 (31.1%) and 12/45 (26.7%) in 2005. Among 52 cases of pneumococcal meningitis that have occurred in vaccinated children (≥1 dose) with PCV7, 7 were due by vaccine serotypes. This study provides data on underlying conditions, penicillin susceptibility, serotype evolution according to vaccination status and risk factors for mortality for pneumococcal meningitis in children from 2001–2005 in France.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References

  1. Bingen E, Levy C, de la Rocque F, Boucherat M, Varon E, Alonso JM, Dabernat H, Reinert P, Aujard Y, Cohen R (2005) Bacterial meningitis in children: a French prospective study. Clin Infect Dis 41:1059–1063

    Article  PubMed  Google Scholar 

  2. Neuman HB, Wald ER (2001) Bacterial meningitis in childhood at the Children’s Hospital of Pittsburgh: 1988–1998. Clin Pediatr (Phila) 40:595–600

    Article  CAS  Google Scholar 

  3. Doit C, Barre J, Cohen R, Bonacorsi S, Bourrillon A, Bingen EH (1997) Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin. Antimicrob Agents Chemother 41:2050–2052

    PubMed  CAS  Google Scholar 

  4. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N (2003) A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349:1341–1348

    Article  PubMed  CAS  Google Scholar 

  5. McCracken GH Jr (1995) Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics. Pediatr Infect Dis J 14:424–428

    Article  PubMed  Google Scholar 

  6. Pickering L, Red Book ( 2003) Report of the commitee on infectious diseases. In: 26 (ed) American Academy of Pediatrics, Elk Grove Village, pp 293–493

  7. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ (2004) Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 39:1267–1284

    Article  PubMed  Google Scholar 

  8. Reinert RR (2004) Pneumococcal conjugate vaccines-a European perspective. Int J Med Microbiol 294:277–294

    Article  PubMed  CAS  Google Scholar 

  9. Cohen R, Gaudelus J, Reinert P, Levy C (2005) Observatory of pediatric practice in vaccinology (ObVac): use of Prevenar®. Médecine et Enfance 25:299–302

    Google Scholar 

  10. Anonymous (2003) French vaccinal calendar. Bull Epidemiol Hebd 6:33–40

    Google Scholar 

  11. Perrocheau A, Doyle A, Bernillon P, Varon EORP, De La Rocque F, Cohen R, Levy Brülh D (2006) Evaluation of the surveillance of paediatric pneumococcal meningitis infections in France, 2001–2002 by capture-recapture method. Bull Epidemiol Hebd 2–3:16–18

    Google Scholar 

  12. National Commitee for Clinical laboratory (2003) Standards performance standards for antimicrobial disk susceptibility testing: thirteenth informational supplement (M100-13). Wayne, Pa

  13. Georges S, Perrocheau A, Laurent E, Levy-Bruhl D, EPIBAC (2005) Bacterial meningitis and invasive disease. EPIBAC. Available at: http://www.invs.sante.fr/surveillance/epibac/default.htm. Accessed

  14. Miller E, Waight P, Efstratiou A, Brisson M, Johnson A, George R (2000) Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996–1998. Acta Paediatr Suppl 89:11–16

    Article  PubMed  CAS  Google Scholar 

  15. Lepoutre A, Varon E, Georges S, Gutmann L, Levy-Bruhl D, EPIBAC (2006) Impact of pneumococcal conjugate vaccination program on incidence of pneumococcal meningitis and invasive disease in children under two years old. EPIBAC. Available at: http://www.invs.sante.fr/presse/2006/le_point_sur/vaccin_antipneumococcique/index.html. Accessed

  16. Weightman NC, Sajith J (2005) Incidence and outcome of pneumococcal meningitis in northern England. Eur J Clin Microbiol Infect Dis 24:542–544

    Article  PubMed  CAS  Google Scholar 

  17. Haddy RI, Perry K, Chacko CE, Helton WB, Bowling MG, Looney SW, Buck GE (2005) Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine. Pediatr Infect Dis J 24:320–323

    Article  PubMed  Google Scholar 

  18. Scheifele D, Halperin S, Pelletier L, Talbot J (2000) Invasive pneumococcal infections in Canadian children, 1991–1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT). Clin Infect Dis 31:58–64

    Article  PubMed  CAS  Google Scholar 

  19. Arditi M, Mason EO Jr, Bradley JS, Tan TQ, Barson WJ, Schutze GE, Wald ER, Givner LB, Kim KS, Yogev R, Kaplan SL (1998) Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 102:1087–1097

    Article  PubMed  CAS  Google Scholar 

  20. Dawson KG, Emerson JC, Burns JL (1999) Fifteen years of experience with bacterial meningitis. Pediatr Infect Dis J 18:816–822

    Article  PubMed  CAS  Google Scholar 

  21. Dagan R, Isaachson M, Lang R, Karpuch J, Block C, Amir J (1994) Epidemiology of pediatric meningitis caused by Haemophilus influenzae type b, Streptococcus pneumoniae, and Neisseria meningitidis in Israel: a 3-year nationwide prospective study. Israeli Pediatric Bacteremia and Meningitis Group. J Infect Dis 169:912–916

    PubMed  CAS  Google Scholar 

  22. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, Lefkowitz L, Perkins BA (1997) Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 337:970–976

    Article  PubMed  CAS  Google Scholar 

  23. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M (2004) Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351:1849–1859

    Article  PubMed  Google Scholar 

  24. Kaplan SL (2002) Management of pneumococcal meningitis. Pediatr Infect Dis J 21:589–591

    Article  PubMed  Google Scholar 

  25. Kastenbauer S, Pfister HW (2003) Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain 126:1015–1025

    Article  PubMed  Google Scholar 

  26. McMillan DA, Lin CY, Aronin SI, Quagliarello VJ (2001) Community-acquired bacterial meningitis in adults: categorization of causes and timing of death. Clin Infect Dis 33:969–975

    Article  PubMed  CAS  Google Scholar 

  27. Tauber MG, Kennedy SL, Tureen JH, Lowenstein DH (1992) Experimental pneumococcal meningitis causes central nervous system pathology without inducing the 72-kd heat shock protein. Am J Pathol 141:53–60

    PubMed  CAS  Google Scholar 

  28. Kaplan SL, Mason EO Jr, Wald E, Tan TQ, Schutze GE, Bradley JS, Givner LB, Kim KS, Yogev R, Barson WJ (2002) Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J 21:141–147

    Article  PubMed  Google Scholar 

  29. McIntyre PB, Macintyre CR, Gilmour R, Wang H (2005) A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis. Arch Dis Child 90:391–396

    Article  PubMed  CAS  Google Scholar 

  30. Pelton SI, Yogev R (2005) Improving the outcome of pneumococcal meningitis. Arch Dis Child 90:333–334

    Article  PubMed  CAS  Google Scholar 

  31. Olivier C, Cohen R, Begue P, Floret D (2000) Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 19:1015–1017

    Article  PubMed  CAS  Google Scholar 

  32. Gonzalez BE, Hulten KG, Lamberth L, Kaplan SL, Mason EO Jr (2006) Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J 25:301–305

    Article  PubMed  Google Scholar 

  33. Kaplan SL, Mason EO Jr, Wald ER, Schutze GE, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Yogev R, Barson WJ (2004) Decrease of invasive pneumococcal infections in children among eight children’s hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 113:443–449

    Article  PubMed  Google Scholar 

  34. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG (2006) Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354:1455–1463

    Article  PubMed  CAS  Google Scholar 

  35. Angoulvant F, Bidet P, Doit C, Aubertin G, Soussan V, Bingen E, Bourrillon A, Faye A (2005) Serotype 6B pneumococcal meningitis in an immunocompetent infant immunized with heptavalent pneumococcal conjugated vaccine. Clin Infect Dis 40:494–495

    Article  PubMed  Google Scholar 

  36. Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, Nyquist AC, Gershman KA, Vazquez M, Bennett NM, Reingold A, Thomas A, Glode MP, Zell ER, Jorgensen JH, Beall B, Schuchat A (2006) Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 368:1495–1502

    Article  PubMed  CAS  Google Scholar 

  37. Clarke SC (2006) Control of pneumococcal disease in the United Kingdom-the start of a new era. J Med Microbiol 55:975–980

    Article  PubMed  CAS  Google Scholar 

  38. Anonymous (2006) French vaccinal calendar. Bull Epidemiol Hebd 20–30:212–226

    Google Scholar 

  39. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A (2003) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348:1737–1746

    Article  PubMed  Google Scholar 

  40. Pebody RG, Hellenbrand W, D’Ancona F, Ruutu P (2006) Pneumococcal disease surveillance in Europe. Euro Surveill 11:171–178

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank all pediatricians and microbiologists who participated in the study: Drs. Adam, Agoli, Akitani, Akli, Alba-Sauviat, Albertini, Aljazayri, Alonso, Amira, Amirault, Amsallem, Andlauer, Andriantahina, Arlet, Armengaud, Arnault, Artigou, Asensi, Aubert, Aucher, Aufrant, Aujard, Auvray, Avignon, Bachelier, Badinand, Banerjee, Barbier, Barbut, Barnaud, Barrans, Barraud, Barré, Bassil, Bataille, Beaufils, Bebear, Bellegra Nourrine, Benezech, Berardi-Grassias, Berche, Berger, Bernard, Berrahma, Berthelot, Berthier, Bessis, Besson-Leaud, Biessy, Bigirimawa, Bineau, Bingen, Terki, Blanc, Blanchard, Bland, Blezel, Retali, Blin, Blondel, Blondin, Boisivon, Bompard, Bonafoux, Bonardi, Bonnin, Boquet, Borde, Born, Bost-Bru, Boudard, Bouillié, Bour, Bourrillon, Boutte, Bouygues, Bouziges, Bowete, Boyer, Branca, Branger, Briand, Brizard, Brocard, Brotslhi, Brouard, Broussine, Brunoni, Bruyas, Budniok, Burel, Lina, Burnichon, Cahiez, Caillaux, Callamand, Calvez, Fellouse, Camboulives, Camenen, Canarelli, Canonne, Cantagrel, Canzi, Carbonnelle, Carre-Cavellier, Carriere, Carriere, Carroger, Castelnau, Barthez, Cattoen, Cau, Caveriviere, Chabrol, Chalvon Demersay, Chami, Chamouilli, Chamoux, Chantelat, Chantepie, Chappet, Charachon, Charara, Chardon, Charras, Chassevent, Chavet, Chenaud, Cheraïtia, Cheron, Chevallier, Chopard, Choulot, Claris, Clergeau, Colin-Gorski, Collignon, Combe, Cometdidierjean, Gury, Cordier, Cormier, Costa, Cottancin, Cottin, Couchot, Coumenges, Courcol, Cousinard, Crepet, Landrot, Croix, Croizé, Crost, Cuntz-Shadfar, Cuvelier, Cuzzi, Dabernat, Dagorne, D’albignac, Dalmon, Daltroff, Danjean-Deguin, Danjoux, Daoudi, Darras, Darviau, Dassieu, David, De Champs, De La Rocque, De Lumley, De Montclos, De Montgolfier, De Preville, De Prunele, De Ricaud, Debray, Decoster, Decoux, Deforche, Dehan, Delacour, Delahaye, Delamare, Delarbre, Delbeke, Deligne, Delisle, Delubac, Demachy, Demarcq, Demarque, Demarquez, Denavit, Denis, Despert, Desprez, Desson, Devictor, Deville, Dib, Dieckmann, Doeuvre, Dolhem, Dommergues, Douard, Douchain, Douillet, Drugeon, Dublanchet, Dubois, Dubourdieu, Duchaine, Poirot, Duhamel, Dulucq, Dumont, Dupic, Dupre, Durand, Duval Arnould, Dzukou, Eb, Eicher, Elchardus, Eloy, Emerique, Enchery, Escarguel, Estournet-Mathiaud, Estrangin, Etienne, Evrard, Faibis, Farges, Faye, Feit, Ferre, Ferroni, Fevre, Fieschi, Fischbach, Floret, Flurin, Forget, Fortier, Fortin,Foucaud, Fournet, Fournier, Francoise, Fremaux, Freysz, Fromont, Fruchart-Flamenbaum, Furioli, Gagliardone, Gaillard, Galanti-Cuyeu, Gallou, Ganivala, Garbarg-Chenon, Garcera, Garnier, Gaudeau-Toussaint, Gaudelus, Gautry, Gavignet, Gbadamassi, Geffroy, Gendrel, Geraudel, Gevaudan, Ghnassia, Ginies, Giudicelli, Glastre, Gold, Goldstein, Goudeau, Gougeon, Goumy, Gouraud, Gout, Goux, Graff, Grancher, Gras-Le Guen, Grasmik, Grelier, Gremillet, Gressier, Grimprel, Grise, Gros, Guesnu, Guibert, Guichard, Guilhaume, Guillaume Bodet, Guillois, Guillot, Guyon, Guyot, Haas, Hachani, Hage, Hallalel, Halna, Hamza, Haouari, Hefteh, Heidt, Hernandorena, Herve, Heusse, Hidri, Hoffmann, Holler, Hubert, Hudebine, Huet, Huin, Huon, Hureaux, Husson, Ikunga, Imbs, Ingrand, Jacob, Jalloul, Jan, Janaud, Jeannoel, Jeannot, Jeny, Jomaa, Joron, Joubert, Joussein, Julien, Jullien, Kaid, Kaiffer, Kermad, Khazaal, Kirch, Kremp, Kretz, Kuntzel, Kurtz, Laboureau, Labrune, Lacomme, Lafargue, Lagier, Laisney, Lajarrige, Laluque, Lambert, Landragin, Langs, Lanotte, Lansiaux, Larroque, Larrouy, Laugier, Launay, Laurens, Laurent, Le Bideau, Le Bouar, Le Gall, Le Loc’h, Le Lorier, Le Luyer, Le Turdu, Lebas, Leblanc, Lecaillon-Thibon, Lecine, Leclerc, Leclercq, Leflon-Guibout, Lefrand-Crepin, Lehnert, Lejeune, Lelioux, Leluan, Lemaitre, Lemble, Lemeland, Lenclen, Lenoir, Lenthel, Leotard, Leraillez, Lesage, Lesbros, Lescanne, Letouzey, Levy, Lhermitte, Cahuzac, Lorotte, Luc, Lucet, Lureau, Lusina, Magny, Maillotte, Mallet, Mancini, Mandelcwajg, Mangeol, Marchand, Marcou, Marie Cardine, Marie Dit Dinard, Marret, Martha Le Gall, Martin, Martinot, Mas, Massard, Masutti, Mathieu, Mattei, Maugard, Mazataud, M’bamba, Megraud, Lehours, Melon, Menetrey, Menget, Menouni-Foray, Merlin, Mettey, Metton, Meunier, Meyer, Michalick, Mikail, Milesi, Milleret-Proyart, Milou, Minery, Mokhtari, Mondaud, Monier, Monin, Monteil, Morales-Gineste, Moreau, Morègne, Moretti, Morice, Moriette, Morin, Morisot, Morville, Motte, Moulene, Moulie, Mounzer, Mselati, Mucignat, Muller, Nardou, Naudion, Nelson, Nerl Schiavini, Netter, Nicolas-Chanoine, Noir, Nordmann, Nouvellon, Orzechowski, Otterbein, Oules, Paget, Pangon, Doucet Populaire, Pannecouck, Paris, Pateyron, Pauchard, Paul, Pautard, Pellerin, Poilly, Pelloux, Penaud, Peralta, Perrin, Peter, Peyrard, Peyraud, Philippe, Philippon, Picaud, Picherot, Pierre, Pierrejean, Pignol, Pinard, Pincemaille, Pincet, Pinquier, Plasse, Ploton, Freydiere, Poilane, Poisson, Pollet, Popelard, Porcheret, Poulain, Pradeaux, Prere, Puech, Queinnec, Quinet, Raber, Raoult, Ravussin, Raymond, Raynaud, Rebaud, Reguet, Reinert, Renaud, Renolleau, Retbi, Reveil, Richardin, Rimet, Rivaux, Riviere, Robin, Rodiere, Rolland, Romanet, Ropert, Rossignol, Rougier, Roussellier, Roybet, Roze, Rudler, Russo, Ryckewaert, Sachs, Sadki, Saf, Saillant, Saliba, Sanchez, Santerne, Sanyas, Sardet, Sarlangue, Sarran, Sartelet, Savoy, Sayegh, Scanvic, Scart, Scat, Schaefer, Schnebelen, Schneider, Schweitzer, Sebag, Secher, Seguin, Semon, Sep-Hieng, Sermet-Gaudelus, Sfez, Sibille, Sicard, Siegel, Smati, Sommabere, Spicq, Stach, Tahiri, Taillebois, Talon, Tchanga, Tessier, Thevenieau, Thibaud, Thibault, Thierry, Thore, Tillier, Tiry, Tixier Ou Vray, Tommasi, Tourrand, Tous, Trioche, Tronc, Turchini, Uzan, Vachee, Valayer, Vallee, Van De Perre, Vandenesch, Vanlaeys, Vasselon-Raina, Vaucel, Vergerond, Vergnaud, Vergne, Vernet-Garnier, Vic, Vidailhet, Vigne, Vigneron, Villemain, Villeneuve, Voyer, Vrillon, Vu Thien, Weil-Olivier, Weisse, Wemeau, Yang Ting, Ygout, Ythier, Zaoui, Zelinsky-Gurung, Zimmermann, Zumbo, Zupan Simunek and Zyka.

We are grateful to A. Lécuyer, N. Kohn and S. Tortorreli for their technical assistance.

We are grateful to C. Picart for the patients’ immunological exploration from the Centre d’Etudes et déficit Immunitaire, Necker Hospital, Paris, France.

We thank David Young for editorial assistance.

Financial support

Pediatric Infectious Diseases Group of the French Pediatrics Society (GPIP) and the Association Clinique et Therapeutique Infantile du Val de Marne (ACTIV).

Potential conflicts of interest

All authors have no conflicts.

Ethical approval

Not needed.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to E. Bingen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bingen, E., Levy, C., Varon, E. et al. Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation. Eur J Clin Microbiol Infect Dis 27, 191–199 (2008). https://doi.org/10.1007/s10096-007-0417-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-007-0417-y

Keywords